Access cutting-edge melanoma treatment through this clinical trial at a research site in New York. Study-provided care at no cost to qualified participants.
Access melanoma specialists in New York at no cost
This study follows strict safety protocols and ethical guidelines
All study-related melanoma treatment provided free
This is a study to investigate the efficacy and safety of an infusion of IOV-4001 in adult participants with unresectable or metastatic melanoma or advanced non-small-cell lung cancer (NSCLC).
Sponsor: Iovance Biotherapeutics, Inc.
Check if you qualify for this melanoma clinical trial in New York, NY
If you're searching for melanoma treatment options in New York, NY, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our New York research site is actively enrolling participants for this clinical trial. You'll receive care from experienced melanoma specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.